These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 31768838)
1. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy. Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838 [TBL] [Abstract][Full Text] [Related]
2. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation. Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice. Song W; Wei L; Du Y; Wang Y; Jiang S Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367 [TBL] [Abstract][Full Text] [Related]
4. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling. Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661 [TBL] [Abstract][Full Text] [Related]
5. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway. Lv C; Cheng T; Zhang B; Sun K; Lu K Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748 [No Abstract] [Full Text] [Related]
6. A novel compound AB-38b improves diabetes-associated cognitive decline in mice via activation of Nrf2/ARE pathway. Chen YJ; Tang ZZ; Du L; Liu Y; Lu Q; Ma TF; Liu YW Brain Res Bull; 2019 Aug; 150():160-167. PubMed ID: 31132419 [TBL] [Abstract][Full Text] [Related]
7. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice. Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377 [TBL] [Abstract][Full Text] [Related]
8. Irbesartan ameliorates diabetic nephropathy by activating the Nrf2/Keap1 pathway and suppressing NLRP3 inflammasomes in vivo and in vitro. Li Y; Long W; Zhang H; Zhao M; Gao M; Guo W; Yu L Int Immunopharmacol; 2024 Apr; 131():111844. PubMed ID: 38503013 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy. Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y Metabolism; 2021 May; 118():154748. PubMed ID: 33675822 [TBL] [Abstract][Full Text] [Related]
10. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy. Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189 [TBL] [Abstract][Full Text] [Related]
11. Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway. Wang S; Zhao X; Yang S; Chen B; Shi J Chem Biol Interact; 2017 Dec; 278():48-53. PubMed ID: 29031534 [TBL] [Abstract][Full Text] [Related]
12. Calycosin modulates NLRP3 and TXNIP-mediated pyroptotic signaling and attenuates diabetic nephropathy progression in diabetic rats; An insight. Yosri H; El-Kashef DH; El-Sherbiny M; Said E; Salem HA Biomed Pharmacother; 2022 Nov; 155():113758. PubMed ID: 36271546 [TBL] [Abstract][Full Text] [Related]
13. Phenethyl isothiocyanate attenuates diabetic nephropathy via modulation of glycative/oxidative/inflammatory signaling in diabetic rats. Eisa NH; Khodir AE; El-Sherbiny M; Elsherbiny NM; Said E Biomed Pharmacother; 2021 Oct; 142():111666. PubMed ID: 34215478 [TBL] [Abstract][Full Text] [Related]
14. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome. Ding T; Wang S; Zhang X; Zai W; Fan J; Chen W; Bian Q; Luan J; Shen Y; Zhang Y; Ju D; Mei X Phytomedicine; 2018 Mar; 41():45-53. PubMed ID: 29519318 [TBL] [Abstract][Full Text] [Related]
15. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome. Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502 [TBL] [Abstract][Full Text] [Related]
16. Renoprotective effect of a novel combination of 6-gingerol and metformin in high-fat diet/streptozotocin-induced diabetic nephropathy in rats via targeting miRNA-146a, miRNA-223, TLR4/TRAF6/NLRP3 inflammasome pathway and HIF-1α. Aboismaiel MG; Amin MN; Eissa LA Biol Res; 2024 Jul; 57(1):47. PubMed ID: 39033184 [TBL] [Abstract][Full Text] [Related]
17. WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling. Zhou X; Liu Z; Ying K; Wang H; Liu P; Ji X; Chi T; Zou L; Wang S; He Z Oxid Med Cell Longev; 2020; 2020():7950457. PubMed ID: 32566101 [TBL] [Abstract][Full Text] [Related]
18. Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming. Liu X; Zhang X; Ding Y; Zhou W; Tao L; Lu P; Wang Y; Hu R Antioxid Redox Signal; 2017 Jan; 26(1):28-43. PubMed ID: 27308893 [TBL] [Abstract][Full Text] [Related]
19. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys. Hou Y; Wang Q; Han B; Chen Y; Qiao X; Wang L Cell Death Dis; 2021 May; 12(6):523. PubMed ID: 34021126 [TBL] [Abstract][Full Text] [Related]
20. Dioscorea zingiberensis ameliorates diabetic nephropathy by inhibiting NLRP3 inflammasome and curbing the expression of p66Shc in high-fat diet/streptozotocin-induced diabetic mice. Ren C; Zhou X; Bao X; Zhang J; Tang J; Zhu Z; Zhang N; Bai Y; Xi Y; Zhang Q; Ma B J Pharm Pharmacol; 2021 Aug; 73(9):1218-1229. PubMed ID: 34061184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]